These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1445 related articles for article (PubMed ID: 12746549)

  • 21. Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93.
    Costenaro L; Kaczmarska Z; Arnan C; Janowski R; Coutard B; Solà M; Gorbalenya AE; Norder H; Canard B; Coll M
    J Virol; 2011 Oct; 85(20):10764-73. PubMed ID: 21835784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
    Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
    J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.
    Lee CC; Kuo CJ; Ko TP; Hsu MF; Tsui YC; Chang SC; Yang S; Chen SJ; Chen HC; Hsu MC; Shih SR; Liang PH; Wang AH
    J Biol Chem; 2009 Mar; 284(12):7646-55. PubMed ID: 19144641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.
    Du Q; Wang S; Jiang Z; Gao W; Li Y; Wei D; Chou KC
    Med Chem; 2005 May; 1(3):209-13. PubMed ID: 16787316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase.
    Blanchard JE; Elowe NH; Huitema C; Fortin PD; Cechetto JD; Eltis LD; Brown ED
    Chem Biol; 2004 Oct; 11(10):1445-53. PubMed ID: 15489171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
    Kandeel M; Al-Nazawi M
    Life Sci; 2020 Jun; 251():117627. PubMed ID: 32251634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism.
    Phakthanakanok K; Ratanakhanokchai K; Kyu KL; Sompornpisut P; Watts A; Pinitglang S
    BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S48. PubMed ID: 19208150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying inhibitors of the SARS coronavirus proteinase.
    Jenwitheesuk E; Samudrala R
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3989-92. PubMed ID: 14592491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
    Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
    J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-range cooperative interactions modulate dimerization in SARS 3CLpro.
    Barrila J; Bacha U; Freire E
    Biochemistry; 2006 Dec; 45(50):14908-16. PubMed ID: 17154528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
    Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
    Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding.
    Pang YP
    Proteins; 2004 Dec; 57(4):747-57. PubMed ID: 15690493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.
    Gan YR; Huang H; Huang YD; Rao CM; Zhao Y; Liu JS; Wu L; Wei DQ
    Peptides; 2006 Apr; 27(4):622-5. PubMed ID: 16242214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
    Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
    J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro.
    Niu C; Yin J; Zhang J; Vederas JC; James MN
    Bioorg Med Chem; 2008 Jan; 16(1):293-302. PubMed ID: 17931870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs.
    Lin CW; Tsai CH; Tsai FJ; Chen PJ; Lai CC; Wan L; Chiu HH; Lin KH
    FEBS Lett; 2004 Sep; 574(1-3):131-7. PubMed ID: 15358553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation analysis of the severe acute respiratory syndrome coronavirus putative non-structural protein 2 gene and construction of three-dimensional model.
    Lu JH; Zhang DM; Wang GL; Guo ZM; Zhang CH; Tan BY; Ouyang LP; Lin L; Liu YM; Chen WQ; Ling WH; Yu XB; Zhong NS
    Chin Med J (Engl); 2005 May; 118(9):707-13. PubMed ID: 15899130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata.
    Hamill P; Hudson D; Kao RY; Chow P; Raj M; Xu H; Richer MJ; Jean F
    Biol Chem; 2006 Aug; 387(8):1063-74. PubMed ID: 16895476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.